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Heart-reactive antibodieshave been found in various cardiovascular diseases (1-3).
In myocarditis and dilated cardiomyopathy autoantibodies to the ADP/ATP carrier,
a protein of the inner mitochondrial membrane, was found (4). The ADP/ATP car-
rier is a transport system within the membranes of euka.ryotic cells enabling direct
nucleotide transport between the intra- and extra-mitochondrial compartments (5).
Autoantibodies against this carrier appear to cause organ-specific inhibition of nucleo-
tide transport (6-8). In animals immunized with the isolated ADP/ATP carrier, the
antibody binding was also found to be organ specific (9).
In this study we investigated the effects of an antibody against the ADP/ATP car-
rier on isolated adult rat myocytes. Immunobinding and immunofluorescence studies
showed that the antibody binds specifically to a cell surface protein. Exposure of
the rat myocytes to the antibody resulted in enhanced calcium current. Prolonged
exposures caused cell damage and death, which was prevented by addition of or-
ganic calcium channel blockers. These studies provide evidence for an interaction
of the antibody against the ADP/ATP carrier with the calcium channel and suggest
a new antibody-mediated mechanism for cytotoxicity and subsequent cell death.
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Materials and Methods
Preparation ofCardiac Myocytes.
￿
Cardiac myocytes were isolated usinga modified enzymatic
procedure (10). Briefly, male Wistar rats, 250-300 g, were killed by a blow to the back of
the neck. The chest was opened and the heart was removed and attached to a Langendorff
perfusion system (11). The heart was perfused for 15 min with calcium-free "high K" buffer
solution (NaCl, 50 mM/1; KCI, 25 mM/1; KH2PO4, 1.21 mM/I; Na2HPO4, 16 mM/I;
MgS04 1.21 mM/I; NaHC03, 25 mM/I; 1% MEM nonessential amino acids; 1% MEM
essential amino acids; 1% MEM vitamins [Boehringer Mannheim Biochemicals, Indianapolis,
IN]; glutamine, 0.68 mM/I; creatine, 20 mM/I; taurine, 60 mM/1; glucose, 11 mM/1) buffered
at pH 7.2-7.4 (10).
The heart was then perfused with another high K buffer containing, in addition, 0.5%
pure BSA (Behring Diagnostics, San Diego, CA), 1.0 mg/ml collagenase (Worthington Bio-
chemical Corp., Freehold, NJ), and 1.5 mg/ml hyaluronidase (Sigma Chemical Co., St. Louis,
MO). The perfusion rate was controlled between 4 and 8 ml/min. After 45-60 min the heart
was removed, minced, and the cells were suspended in a fresh high K buffer containing en-
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zyme mixture for 10 min. After the first 5 min of incubation, calcium was added to give a
final concentration of 25 PM Ca2'. The cell suspension was filtered through a 300-gm nylon
mesh and, to remove dead cells and fibroblasts, the cell suspension was separated by a BSA
gradient centrifugation (10). The final cell pellet was suspended in low K buffer solution (NaCl,
121 mM/1; KCI, 4.85 mM/I; KH2PO4, 1.21 mM/1; Na2HP04, 16 mM/I; Mg504, 1.21 mMA;
1% MEM nonessential amino acids; 117o MEM essential amino acids; 1% MEM vitamins
(Boehringer Mannheim Biochemicals); glutamine, 0.68 mM/I; creatine, 20 mM/l; taurine,
60 mM/I; glucose, 11 mM/1 ; 0.5% BSA; CaC12 , 0.1 mM/1) buffered at pH 7.2-7.4 for fur-
ther use.
Cell Counting.
￿
Cell morphology was examined by light microscopy and the total number
of cells was determined by a hemocytometer (Fuchs-Rosenthal, Wertheim, FRG). The per-
centage of cells that were rod shaped with clear striations and that excluded 0.4% trypan-blue
were measured. Cell yields were calculated by measuring the volume ofthe final cell suspension.
Analytical Procedures.
￿
Protein content was determined by a biuret procedure (12). The ATP
content of the cells was determined enzymatically in acid extracts (13, 14).
Antibodies and Solidphase RIA (SPRIA)'.
￿
Immunization of rabbits with the ADP/ATP car-
rier, purification of the antisera and the preimmune sera to IgG fractions, and the indirect
micro-SPRIA were carried out as described previously (9, 15). For affinity purification of
antibodies to the ADP/ATP carrier, purified ADP/ATP carrier protein was bound to nitrocel-
lulose paper. The free binding sites were blocked by 1 17o Tx or albumin. After a 12-h incuba-
tion with antiserum followed by several washes with a solution (NaS04, 100 mM/I; mor-
pholinopropanesulfonic acid (MOPS), 10 mM/1; EDTA, 0.05 mM/1; 0.50 Io Triton-X 100 [Tx];
0.05% NaN3) buffered at pH 7.2 .
Bound antibodies were released by a 15-30 min incubation with 0.1 M citric acid, pH
2 .5. The obtained purified IgG solution was immediately neutralized with saturated Tris buffer,
pH 7 .4, then extensively dialyzed against PBS, and was concentrated to the original serum
volume used for adsorption. The purification procedure was done at 4°C. Chromatographical
affinity purification was not attempted because ofthe instability ofthe antigen at the column.
Immunofluorescence Studies.
￿
Cryosections (4 pm) from rat and rabbit cardiac tissue were
obtained with a cryostate (Linde, Koln, FRG) at -22'C. The sections were incubated with
20 pl of affinity-purified IgG to the ADP/ATP carrier for 30 min at room temperature. Cell
surface staining of isolated cardiac myocytes was done at 10°C in PBS. Suspended living
cells were incubated with affinity-purified antibodies for 30 min. For control experiments,
the antibodies were replaced by rabbit preimmune IgG or by antibodies to the ADP/ATP
carrier previously adsorbed to the purified antigen (100 pg antigen/1 ml antibody dilution
1 :50, 3 h, 0°C). As secondary antibody, goat anti-rabbit IgG conjugated to fluorescein
isothiocyanate was used in a dilution of 1 :40. This procedure was the same for cryosections
and living monocytes. Fluorescence microscopy of labeled tissue and cells was carried out
with a microscope (Orthoplan, Wetzlar, FRG) equipped for immunofluorescence. Pictures
were taken on a Gilford HPS film.
Radioimmunobinding Assay.
￿
To detect bound antibodies, the cells were tested using a radio-
immunobinding assay. 2 x 105 myocytes in 400 pl "low K" buffer were incubated with anti-
bodies (IgG fraction) at different concentrations and for different times. The myocytes were
then washed with low K buffer and centrifuged (20 g; 40 s; three times). 1251-protein A (sp
act, 9 .8 pCi/gg; NEN) was used to label the bound antibodies (20,000 cpm/2 x 105 cells)
for 1 h. After incubation at room temperature the cells were washed with low K buffer once
more and recentrifuged (20 g; 40 s; four times). The final pellet was measured for radioac-
tivity in a gamma counter (Gammaszint BF 5300; Berthold, Munchen, FRG). The data were
then normalized to 106 cells for comparative quantification.
Gel Electrophoresis and Immunoblot Analysis.
￿
Proteins were separated in a Laemmli buffer
system (16) on 5-18°Jo polyacrylamide slab gels. Gels were stained with silver nitrate using
a modified technique of Oakley et al. (17). Immunoblotting was performed accordingtoTowbin
et al. (18) on nitrocellulose sheets (4°C; overnight; 0.1 A). The nitrocellulose was rinsed with
'Abbreviations used in this paper: MOPS, morpholinopropanesulfonic acid; SPRIA, solid-phase RIA;
TTX, tetrodotoxin; Tw, Tween 20; Tx, Triton-X 100.SCHULTHEISS ET AL.
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PBS containing 17o Tw to reduce unspecific binding, and then incubated with antibody solu-
tions (IgG; 1 :400) overnight at 40C. After washing with PBS/Tween 20 (Tw) the sheets were
incubated with peroxidase-conjugated goat anti-rabbit IgG (Miles Laboratories Inc., Naper-
ville, IL) (1 :400) and were washed again and analyzed by staining with 4-chloro-naphthol
(0.5 mg/ml).
Measurements of Cytotoxicity.
￿
In each case 5 x 104 myocytes were incubated in 1 ml low
K buffer for 1 h with varying concentrations antibody from 1:25 to 1 :6,400; at (Ca2' )o of
1 mM; for varying times up to 180 min with an antibody concentration of 1:100 and (Ca2'
)a
of 1 mM; for varying times up to 180 min and varying calcium concentrations of0, 0.1, 0.5,
and 1 mM at an antibody concentration of 1:100; and for 1 h after preadsorption of the
antibody with its antigen (100 Rg antigen/l ml antibody dilution 1 :100; 3 h). After the given
times or concentration steps, the cells were counted and examined for their viability, as de-
scribed in the previous section, Cell Counting.
Whole Cell ElectricalMeasurements.
￿
Isolated rat ventricular myocytes were voltage clamped
using the whole cell patch clamp technique (19, 20). Cells were dialyzed with solutions con-
taining high Cs' in order to block the potassium currents. The pipet solution contained:
CsCl, 100 mM/l; EGTA, 10 mM/l; CaC12, 1.0 mM/l; Hepes, 20 mM/l; glucose, 10 mM/l;
Mg-ATP, 5 mM/1; c-AMP, 0.2 mM/l; buffered at pH 7 .3. 10-5 M tetrodotoxin (TTX) was
used in the bathing solutions to block the fast sodium current. The bathing solution con-
tained: NaCl, 120 mM/l; CaC12, 1-5 mM/l; KCI, 3 mM/1; glucose, 10 mM/l; Hepes, 10
mM/l; buffered at pH 7.4.
Results
Structurefunction Characteristics oftheIsolated CardiacMyocytes.
￿
The enzymatic isola-
tion technique used in this study yielded a large number (4.2 t 0.9 x 106) of
healthy cells from adult rat hearts. Using exclusion of trypan blue in combination
with rod-shaped morphology as criteria of cell viability, we found 84.1 t 4.4% of
the cells to be viable. Rod-shaped cells had clear cross striations, and were calcium
tolerant (Fig. 5a). A very small fraction of cells contracted spontaneously at very
low frequencies. The mean protein content of our cells was 5 .4 t 1.8 ng, and the
cellular ATP content of20.5 t 3 .8 nM/mg protein per myocyte was in good agree-
ment with previous studies (14, 21, 22). The cells remained viable for at least 8 h.
Identification andSpecificity oftheAntibody againsttheADP/ATPCarrier.
￿
Fig. 1 a shows
the antibody binding to the antigen, the ADP/ATP carrier. The protein was isolated
as described before (5, 9). After coating with antigen, the titer plates were incubated
with decreasing amounts of antiserum (affinity-purified IgG) and the bound anti-
bodies were detected with 1251-protein A. The preimmune serum IgG was used as
control. Preincubation of the antibodies with different concentrations of antigen and
subsequent SPRIA measurement resulted in an inhibition of antibody binding (Fig.
1 b), indicating the specificity of the antibody to the ADP/ATP carrier.
Gel electrophoresis ofthe isolated ADP/ATP carrier (Fig. 2 a) and the subsequent
immunoblot showed only one band with a molecular mass of 30 kD. To prove whether
the antiserum reacted with another protein of the mitochondrial fraction used for
isolation of the carrier protein, we blotted mitochondrial membranes on nitrocellu-
lose sheets and incubated them with the anti-ADP/ATP carrier serum. As seen in
Fig. 2, lane d, the antibody again only reacted with the 30-kD band. After preincu-
bation of the serum with the isolated carrier protein, no antibody binding to the
nitrocellulose was detected anymore. Based on these data, one can assume that anti-
bodies raised against the ADP/ATP carrier only react with this mitochondrial pro-
tein. Moreover, the specific immune reaction of the antibodies with only one single2108
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FIGURE 1 .
￿
Binding ofthe antibody to
its antigen, the ADP/ATP carrier, in
---~-
￿
- ￿SPRIA . (a) Concentration-dependent
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antibody binding to the purified ADP/
antibody dilution
￿
ATP carrier. (b) Inhibition of antibody
binding after preincubation with the
purified ADP/ATP carrier. Antisera in
a dilution of 1 :1,000 and 1 :2,000 were
incubated with increasing amounts of
the purified ADP/ATP carrier andthen
measured for residual binding.
band makes an additional interaction of the antibodies with a minor containment
quite unlikely.
TheAnti-ADP/ATP Carrier Antibody Binds to Cardiac Tissue andMyocytes .
￿
Cryosec-
tions of rat, rabbit, and human cardiac tissue incubated with antibodies to the
FIGURE 2 .
￿
Gel electrophoresis
(A and B) and immunoblot (C
andD) ofthe purified ADP/ATP
carrier (A and C) and total mi-
tochondrial proteins from heart
(B and D); molecular weight
standard (E). The proteins were
separated on SDS polyacryl-
amide gels . One section of the
gels were stained with coomas-
sie blue (A, B, and E), the other
section was electrophoretically
blotted on a nitrocellulose sheet,
incubated with the anti-ADP/
ATP carrier antiserum, and
then with peroxidase conju-
gated anti-IgG (C and D) .SCHULTHEISS ET AL.
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FIGURE 3 . Immunofluores-
cenceon cardiac tissue and iso-
lated cardiac myocytes . (a)Im-
munofluorescence staining of
mitochondria and cell surface in
cross-sections of human papil-
lary muscle with anti-ADP/ATP
carrier antibodies. (b) Disap-
pearance ofcell surface and in-
tracellular reaction after neu-
tralization ofantibodieswith the
purified ADP/ATP carrier anti-
bodies. (c) Cell surface staining
of isolated adult rat cardiac
myocytes with anti-ADP/ATP
carrier antibodies .
ADP/ATP carrier (affinity-purified IgG) showed bright immunofluorescence on mi-
tochondrial structures and the cell surface . Fig . 3, a and b compares the staining
ofhumanpapillary muscle with antibodies to the ADP/ATP carrierbefore and after
its neutralization with the ADP/ATP carrier. The bright immunofluorescence dis-2110
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appeared from the tissue (Fig. 3 b). Preimmune sera (IgG) did not react with any
cardiac tissues examined. The antibody (affinity-purified IgG) also stained the sur-
face of cardiac myocytes (Fig. 3 c) and could be completely neutralized with the
ADP/ATP carrier. Theseresultssuggest specificity ofthe immune reaction and pro-
vide evidence that the antibody against ADP/ATP carrier crossreacts immunologi-
cally with antigenic determinants on the cell surface. The crossreactivity between
the ADP/ATP carrier of the inner mitochondrial membrane and a protein of the
cell surface was also demonstrated by a radioimmunobinding assay. Fig. 4 a shows
that one-halfmaximumbindingof antibodies to the cell surfaceoccurs after 15 min.
Preimmune serum IgG (control) did not bind to the surface of myocytes. Antibody
dilution from 1:1,000 to 1:6,000 resulted in a reduction of total antibody binding.
No significant antibody binding could be detected at dilutions of 1 :5,000 (Fig. 4
b). The specificity ofthe antigen-antibody reaction was examined by preadsorption
of the antibody to an increasing amount of the isolated ADP/ATP carrier (1-1,500
ng). Fig. 4cshowsthat increasing the concentration oftheADP/ATP carrierreversed
the antibody binding to the cell surface. These results clearly indicate the existence
of acell surface proteinthat interactscompetitively with theantibodies directed against
the ADP/ATP carrier.
Antibody-mediated Cytotoxicity.
￿
Incubation of isolated cardiac myocytes with an an-
tibody concentration of antibody >1 :1,000 resulted in a concentration-dependent
cell deterioration and death. Cell deterioration was monitored visually. It was ac-
companied by oscillatory contractions, bleb formation, cell shortening, granulation,
and finally, cell rounding (Fig. 5, a-c). Rounded cells took up trypan blue rapidly
while rod-shaped cells excluded the dye completely. The ATP content of such cells
decreased from 20.5 ± 3.8 to <10 nM/mg protein in a cell suspension incubated
for 2 h with antibody dilutions of 1:100.
Using an antibody concentration of 1:100 in cell suspensions containing 1 mM
calcium, 20% of the myocytes rounded up after 30 min, 40% after 1 h, and N80%
after3 h. In contrast, only 10-15% ofthe myocytes incubatedwith preimmune serum
IgG appeared to be damaged after 3 h (Fig. 6). Decreasing the external calcium
concentration decreased the antibody-mediated cytotoxicity. In absence of added
calcium with antibody concentrations of 1:100, only 10% of the cells appeared to
be damaged after 3 h (Fig. 6). Preadsorption of the antibody with its antigen, the
ADP/ATP carrier, markedly reduced cytotoxicity (27% damagedcells after 3 h, not
shown).
To examine whether cytotoxicity was mediated by increased calcium current, the
effect of calcium channel antagonists on the time-dependent antibody-induced cell
damage was tested. Fig. 7 shows that calcium channel blockers markedly reduced
the cytotoxic effect of the antibodies. Nifedipine and nitrendipine (10-6 M) seemed
to be more effective in protecting against cell damage than was verapamil (10-6 M).
In the absence of antibodies, calcium channel antagonists had no effect on time-
dependent cell viability (Fig. 7).
The effects ofAntibody on the Calcium Current ofIsolated Cardiac Myocytes.
￿
The results
thus far suggest that the antibody binds specifically to the cell surface of cardiac
myocytes and enhances their calcium permeability leading to cell damage. To gain
further evidence for a direct interaction ofthe anti-ADP/ATP carrierantibodies with
the calcium channel, we isolated the calcium channel protein complex according
to the method of Campbell (30). After SDS gel electrophoresis and transfer of thec
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FIGURE 4.
￿
Bindingofanti-ADP/
ATPcarrierantibodies to isolated
cardiac myocytes measured with
radioimmunobinding assay. (a)
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protein to nitrocellulose paper, the immunoblot analysis showed that the affinity-
purified antibodies against the ADP/ATP carrier protein bind to the different cal-
cium channel subunits (Fig. 8). These data clearly indicate acrossreactivity between
theADP/ATP carrier ofthe innermitochondrial membrane andthe calcium channel
located within the cell surface membrane.
Therefore in another series of experiments, we examined the possible effects of2112
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FIGURE 5 .
￿
Appearance of isolated cardiac myocytes duringincubation with anti-ADP/ATP car-
rier antibodies (dilution 1:100, 1 mM Ca21) . (a) Normal, rod-shaped cell ; (b) after 30 min : cell
shortening, granulation, bleb formation ; (c) after 1 h : final cell death .SCHULTHEISS ET AL.
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FIGURE 6.
￿
Calcium concentration and time-dependent mortality of isolated cardiac myocytes
incubated with anti-ADP/ATP carrier antibodies; antibody (IgG) dilution, 1:100.
the antibody on the calcium current in isolated rat myocytes. Myocytes were patch
clamped in control tyrodes (1-5 mM Cal') and the magnitude of Ica and its ki-
netics were examined. Cells were dialyzed with high concentrations of Cs' and
TEA' in order to block the K" currents. Intracellular calcium concentration was
buffered at -10-8 M, using 11 mM EGTA and 1 mM Cal'. INa was inactivated
and blocked using a combinationof TTX (10- 5 M) and holding potentials of -40
to -50 mV Ica was then activated by step depolarization to different potentials from
-50 mV Fig. 9 shows that addition of antibody enhances Ica rapidly. Peak ICa in-
creased by -50-100%. The inactivation of 1ca was also markedly slowed in the pres-
ence of the antibody (Fig. 8 inset), leading often to activation of large "tail" currents
accompanying the termination of the clamp pulse. The effect of antibody on Ica
was slowly reversible on washout of the antibody. Peak Ica often decreased below
control levels, consistent with often-observed "run-down" of Ica. The enhancement
of the Ica by the antibody was reversibly blocked by Nifedipine (10-6 M). R blockers
(e.g., propranolol at 10-6 M) did not affect the antibody-induced enhancement of Ica.
The potentiating effect of the antibody on the Ica was often variable. Fig. 10 il-2114
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FIGURE 7 .
￿
The effects ofthe calcium
channel antagonists nitrendipin, nifed-
ipin, andverapamil andthe ß blocker
propranololon the mortality ofisolated
cardiac myocytes incubated with anti-
ADP/ATP carrier antibodies . 3 x 105
myocytes in 1 ml washing buffer con-
taining 0.5% ESA and 1 mM Ca2'
were incubated either with the calcium
antagonists or the ß blocker for5min.
Subsequently, to one half of the cells,
ADP/ATP carrier antibodies were
added in a final concentration of 1 :100,
and control serum was added to the
otherhalf(1:100). After 0, 30, 60, 120,
and 180 min, the cells were counted
andexamined for their variability (see
Material and Methods) .
FIGURE 8 .
￿
Time course of antibody effect on ICa in a rat ventricular myocyte. (Inset) Original
superimposed traces of ICa upon addition of antibody (1 :500) . Addition of antibody strongly
enhanced peak ICa in this cell . Reversal ofthe effect was slow. Room temperature, 24°C; (Ca2+ )o,
2.0 mM ; TTX, 10-5 M .SCHULTHEISS ET AL.
￿
2115
FIGURE 9.
￿
Effect of antibody
on calcium current intwo differ-
ent rat ventricular cells . Upper
and lower panels representtwo
different cells subjected to anti-
body concentrations of 1 :100 .
In upper left panel, peak Ica
does notseem to have increased,
although the time course of in-
activation is markedly slowed
(T52-trace). Wash out ofthe an-
tibody (W) (upperrightpanel) re-
veals larger potentiating effect
of antibody on peak Ica . Most
likely because Ica is known to
run down during the time
course of experiments . (Lower
leftpanel) In another cell where
Ica was more stable, antibody
induces potentiating effect on
peak Icaand slows its inactiva-
tion . Lower right panel repre-
sents complete reversal ofanti-
body effect (W) . (Ca2+ )o, 2.0
mM;room temperature, 24°C ;
Holding potential, -50 mV;
TTX, 10- sM.
lustrates the effect of the antibody on peak and the maintained components of Ica
in two different cells . In one cell the antibody appeared to enhance only the main-
tained component of Ica , with little or no apparent effect on the peak Ica (Fig. 10,
upper left panel), while in the other, both the maintained and the peak Ica were
FIGURE 10 .
￿
Gel electrophoresis and
immunoblot of the isolated calcium
channel protein (30),The isolated cal-
cium channel protein was separated
on SDS polyacrylamide gels. Lane B
was stained with coomassie blue, lane
Cwas incubated after the transfer to
nitrocellulose with affinity-purified an-
tibodies (IgG) against the ADP/ATP
carrier and stained with peroxidase-
conjugated anti-IgG; molecular weight
standard (C) .2116
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enhanced (Fig. 10, lower left panel) . This effect is most likely due tovariable run-down
of Ica in these two cells, since the washout of the antibody in the cell depicted in
the upper panels leads to a decrease in peak Iea significantly below control level.
Consistent with this idea was the finding that in the frog ventricularmyocytes where
the run-down of ICa is very slow, the antibody consistently and reversibly poten-
tiated peak Ica (not shown). These results thus support the idea that the antibody
crossreacts with a surface membrane protein, most likely the calcium channel in
bringing about the above-described effects.
Discussion
The experimentsdescribed hereprovide evidence fora crossreactivityofantibodies
against the ADP/ATP carrier ofthe inner mitochondrial membrane with a protein
ofcell surface, mostlikely thecalcium channel. Themain observations ofthisreport
are that this antibody enhances ICa and the cellular calcium permeability, which
may lead to the observed cytotoxicity.
Evidence for crossreactivity of the antibody against the ADP/ATP carrier with
a cell surface protein ofcardiac myocytes was obtained from several experiments.
In immunofluorescence studies, the antibody against theADP/ATP carrier, not the
preimmune serum, stained the cardiac cell membrane. After neutralization ofthe
antibodies with the purifiedADP/ATP carrier, no immunofluorescence stainingwas
detected anymore, indicating the specificity ofthe immunoreaction. These data are
in good agreement with those obtained by radioimmunobinding tests, which show
a time- and concentration-dependent binding of the antibodies to the cell surface.
Once again, neutralization ofthe antibody bindingto the cell surface by preincuba-
tion of the antibodies with the isolated ADP/ATP carrier demonstrates the high
specificity ofthis reaction. Together, these results indicate the existence ofa cross-
reactionbetween theADP/ATP carrier and a sarcolemmal proteinofcardiacmyocytes.
Although we can not totally exclude that the "crossreacting antibody" is directed
against a minor contaminant in the ADP/ATP carrier preparation, the data shown
indicate that the vast majority of the antibodies is directed against the 30-kD pro-
tein. Consideringthe magnitude ofcrossreaction and thelack ofany detectable pro-
tein byelectrophoresis and immunoblot technique, the immunogenicity ofthiscon-
taminant moeity and the affinity of the resulting antibody would have to be in an
unimaginable range.
Prolonged exposure of cardiac myocytes to high concentrations of antibody ex-
hibited a cytotoxic effect. The antibody-mediated cytotoxicity wasthought tobecaused
directly by the IgG fraction ofthe serum and was not complement dependent, be-
cause cytotoxicity couldbe induced by affinity-purified IgGin the serum-free media.
This observation indicatesanew mechanism foran antibody-mediated complement-
independent cytotoxicity (23, 24). Cytotoxicity appeared to result from increased
cellular permeability to calcium, causing oscillatory contractions and calcium over-
load (25-27). Consistent with this assertion, cytotoxicity was prevented, in order of
effectiveness, by: removal of(Ca2+)o, addition ofcalcium channel blockers, and neu-
tralization of antibody. Thus, the antibody-mediated cytotoxicity may have devel-
oped secondary to the enhanced calcium permeability of the myocytes.
Three types ofstudies suggestthat the enhanced calcium permeability mostlikely
is caused by an antibody binding to the calcium channel. (a) ImmunofluorescenceSCHULTHEISS ET AL.
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and binding studies suggest large binding of the antibody to the cell surface. The
resulting antibody-induced cell damage could be reversed by nifedipine, nitrendi-
pine, and verapamil, and on withdrawal of (Ca").. (b) The rapid enhancement of
ICaby the antibody in the isolated myocytes also strongly suggests that the antibody
interacts directly with the Ca2+ channel modifying its permeability. The {3 receptor
does not appear to mediate this action of the antibody, since neither lI blockers nor
the presence or absence of c-AMP in the dialyzingpatch pipet solution altered the
antibody effect on Iea. These experiments suggest, -therefore, that the antibodies
against the ADP-ATP carrier interact with asite closelyassociated with thecalcium
channel, enhancing ICa most likely by increasing the mean open time of the channel.
(c) Supporting evidence for this assertion comes from the finding that the antibody
against the ADP/ATP carrierbinds directly to the isolated calcium channel protein.
It has been recently suggested that there may be acommon structural similarity
betweenvarious membrane channels (28, 29). A high degree of structural similarity
between gap junction polypeptide, sodium channel, and nicotinic acetylcholine
receptor has already been described (28). Furthermore, similarities were reported
between several voltage-gated channels (K, Na, Ca). The data presented here also
show acrossreactivity betweentwodifferent transportproteins, however, forthe first
time between aprotein ofthe innermitochondria) membrane andacell surface pro-
tein. As the crossreacting antibodies influence the function of both proteins, this
might indicate a similar mode of function and a common evolutionary origin for
both proteins.
Abnormalities in calcium metabolism of myocardium are thought to be involved
in pathogenesis ofcardiomyopathies (31-33). So farthe mechanism underlying di
turbed calcium metabolism is not clear. As we can show that antibodies against the
ADP/ATP carrier, also found in myocarditis and dilated cardiomyopathy (4, 6, 7,
34), crossreact with the calcium channel, these antibodies could be responsible for
the disturbance of calcium homeostasis by enhancing calcium current. This may
lead to an an antibody-mediated calcium overload and subsequent cell death (35).
Thus, the data presented could be of great clinical relevance in the understanding
of the pathogenesis of these suspected autoimmune diseases (36, 37).
Summary
Our study shows that antibodies, specific to the ADP/ATP carrier of the inner
mitochondria)membrane, crossreact with thecell surfaceofcardiac myocytes, where
the calcium channel seemsto be the antigenicdeterminant. The antibodies enhanced
thecalcium currentand suppressed its inactivation. Affinity-purified antibodies (IgG)
exhibit an acute cytotoxic effect, which required extracellular calcium and was
preventedby calciumchannelblockers. Ourfindings suggestthat antibody-mediated
cytotoxicity results secondary to calcium overload caused by enhanced cellular cal-
cium permeability, requiring no complement-dependent process.
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